CTC Foundation of Princeton donating $100,000 to Hepatitis B Foundation
Doylestown, Pa., Feb. 3, 2022 – The CTC Foundation of Princeton, N.J., is donating $100,000 over five years to the Hepatitis B Foundation, a global nonprofit organization that is engaged in advocacy, education and research to combat hepatitis B, the most common serious liver infection in the world.
“The CTC Foundation chooses to support the Hepatitis B Foundation because of the extraordinary people who founded it decades ago, the vision and commitment of the leadership team they assembled, and the breadth of impact this dedicated group continues to cultivate,” the CTC Foundation’s Board of Trustees said. “We believe that multi-year support is critical for the Foundation, to know that there is funding available to execute initiatives in their strategic plan to end hepatitis B.”
Chari Cohen, DrPH, MPH, senior vice president of the Hepatitis B Foundation, said: “We are very appreciative of this generous support and the continued commitment of the CTC Foundation. This donation will help support our unique patient engagement program, so that we can continue to improve the quality of life of people living with hepatitis B, and ensure that their voices play a meaningful role in drug and clinical trial development.”
Jean Holmes, MBA, the Hepatitis B Foundation’s vice president for institutional advancement, said: “All of us at the Hepatitis B Foundation are thrilled that the CTC Foundation has worked with us to commit to five years of support. This is a key contribution to our Leading the Way to a Cure campaign and we are very grateful for their faith and generosity.”
The CTC Foundation is a small family organization with roots in the Mid-Atlantic area. Its mission is to promote educational, cultural and scientific endeavors through charitable giving.
About Hepatitis B: A potentially fatal disease caused by the hepatitis B virus, it attacks and injures the liver. Each year up to 1 million people die from hepatitis B worldwide, even though it is preventable and treatable. The number of adults living in the U.S. who have chronic hepatitis B infection may be as high as 2.4 million, which is nearly three times greater than the federal government’s official estimate, according to a new report by a team of public health experts, scientists and physicians. Hepatitis B is a “silent epidemic” because most people do not have symptoms when they are newly or chronically infected. Thus, they can unknowingly infect others and continue the spread of hepatitis B. For people who are chronically infected but don’t have any symptoms, their livers are still being silently damaged, which can develop into serious liver disease such as cirrhosis or liver cancer.
About the Hepatitis B Foundation: We are the nation’s leading nonprofit organization solely dedicated to finding a cure for hepatitis B and improving the quality of life for those affected worldwide through research, education and patient advocacy. Founded in 1991, the Hepatitis B Foundation is based in Doylestown, Pa., with an office in Washington, D.C. To learn more, go to www.hepb.org, read our blog at hepb.org/blog, follow us on Twitter, Instagram and Facebook (@hepbfoundation) or call us at 215-489-4900. To donate, contact Jean Holmes at 215-489-4900 or jean.holmes@hepb.org.